Given that both TPC2 and TRPML1 are lysosomal calcium channels of distinct families implicated in cancer progression, TRPML1 served as a comparative control to determine whether observed effects are unique to TPC2 or reflect a broader lysosomal calcium signalling phenomenon. The gene discussed is TPCN2; the disease is cancer.